Robinson Chandler

Monopar Therapeutics Inc. · Chief Executive Officer

Robinson Chandler is listed in public filings as director, officer: Chief Executive Officer. This Robinson Chandler insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Monopar Therapeutics Inc. (MNPR). Investors use Robinson Chandler's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Monopar Therapeutics Inc.MNPR	--92.5k shares	Grant / ExerciseMar 31, 2026	Disclosure amount unavailable6.7k shares	--	--
Monopar Therapeutics Inc.MNPR	$5.0M90.5k shares	Grant / ExerciseMar 31, 2026	$108.0K2k shares	$54.79	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Monopar Therapeutics Inc.MNPR	--88.3k shares	Grant / ExerciseDec 31, 2025	Disclosure amount unavailable8.7k shares	--	--
Monopar Therapeutics Inc.MNPR	$5.6M85.7k shares	Grant / ExerciseDec 31, 2025	$167.0K2.6k shares	$65.30	--
Monopar Therapeutics Inc.MNPR	$1.3M16.8k shares	Grant / ExerciseDec 2, 2025	$1.3M16.8k shares	$75.94	--
Monopar Therapeutics Inc.MNPR	--121.7k shares	Grant / ExerciseDec 2, 2025	Disclosure amount unavailable49.1k shares	--	--
Monopar Therapeutics Inc.MNPR	$6.5M79.6k shares	Grant / ExerciseSep 30, 2025	$216.1K2.6k shares	$81.67	--
Monopar Therapeutics Inc.MNPR	--72.6k shares	Grant / ExerciseSep 30, 2025	Disclosure amount unavailable8.7k shares	--	--
Monopar Therapeutics Inc.MNPR	$2.9M73.5k shares	SellJul 14, 2025	$672.0K16.8k shares	$40.00	--
Monopar Therapeutics Inc.MNPR	$016.8k shares	OtherJul 14, 2025	$8416.8k shares	$0.005	--
Monopar Therapeutics Inc.MNPR	$2.6M73.5k shares	Grant / ExerciseJun 30, 2025	$209.8K5.9k shares	$35.78	--
Monopar Therapeutics Inc.MNPR	--79.3k shares	Grant / ExerciseJun 30, 2025	Disclosure amount unavailable13.3k shares	--	--
Monopar Therapeutics Inc.MNPR	--67.2k shares	Grant / ExerciseMar 31, 2025	Disclosure amount unavailable4.1k shares	--	--
Monopar Therapeutics Inc.MNPR	$2.4M66k shares	Grant / ExerciseMar 31, 2025	$43.8K1.2k shares	$36.41	--
Monopar Therapeutics Inc.MNPR	$2.7M85.8k shares	Grant / ExerciseMar 4, 2025	$2.7M85.8k shares	$31.70	--
Monopar Therapeutics Inc.MNPR	--64.9k shares	Grant / ExerciseMar 4, 2025	Disclosure amount unavailable6k shares	--	--
Monopar Therapeutics Inc.MNPR	--104.8k shares	Grant / ExerciseMar 4, 2025	Disclosure amount unavailable79.9k shares	--	--
Monopar Therapeutics Inc.MNPR	$2.0M63.1k shares	Grant / ExerciseMar 4, 2025	$55.8K1.8k shares	$31.70	--
Monopar Therapeutics Inc.MNPR	--62.8k shares	OtherJan 28, 2025	Disclosure amount unavailable62.8k shares	--	--
Monopar Therapeutics Inc.MNPR	--24.9k shares	Grant / ExerciseDec 31, 2024	Disclosure amount unavailable4.9k shares	--	--
Monopar Therapeutics Inc.MNPR	$1.3M58.8k shares	Grant / ExerciseDec 31, 2024	$48.6K2.2k shares	$22.00	--
Monopar Therapeutics Inc.MNPR	--29.8k shares	Grant / ExerciseSep 30, 2024	Disclosure amount unavailable4.9k shares	--	--
Monopar Therapeutics Inc.MNPR	$379k56.2k shares	Grant / ExerciseSep 30, 2024	$12.9K1.9k shares	$6.74	--
Monopar Therapeutics Inc.MNPR	--173.3k shares	Grant / ExerciseJun 30, 2024	Disclosure amount unavailable24.5k shares	--	--
Monopar Therapeutics Inc.MNPR	$194k265.9k shares	Grant / ExerciseJun 30, 2024	$6.3K8.7k shares	$0.731	--